57 completed, 15 terminated, 9 unknown, 7 withdrawn. 31 Phase 1, 28 Phase 2, 9 Not applicable, 2 Early Phase 1, 1 Phase 3.
Follow immunoenzyme technique: new trials by email Literature Review of immunoenzyme technique trials Research Report on immunoenzyme technique
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Edible Hepatitis B Vaccine Therapy in Healthy Participants Who Have Undergone Previous Vaccination hepatitis B antigen peptide, placebo, immunoenzyme technique - Healthy, no Evidence of Disease | Not applicable | Withdrawn | Roswell Park Cancer Institute | 2013-02-01 | 2022-10-03 | |
| Ex Vivo-Expanded HER2-Specific T Cells and Cyclophosphamide After Vaccine Therapy in Treating Patients With HER2-Positive Stage IV Breast Cancer HER-2/neu peptide vaccine, cyclophosphamide, ex vivo-expanded HER2-specific T cells - HER2-positive Breast Cancer, Male Breast Cancer | Phase 1 | Withdrawn | University of Washington | 2012-06-01 | 2013-05-17 | |
| Biomarkers in Samples From Patients With Chronic Lymphocytic Leukemia Treated on Clinical Trial ECOG-2997 cytogenetic analysis, flow cytometry, fluorescence activated cell sorting - Leukemia | Completed | ECOG-ACRIN Cancer Research Group | 225 | 2012-04-17 | 2017-05-17 | |
| Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer laboratory biomarker analysis, enzyme-linked immunosorbent assay, flow cytometry - Recurrent Colon Cancer, Recurrent Gastric Cancer | Phase 1 | Completed | City of Hope Medical Center | 12 | 2011-12-22 | 2026-10-19 |
| Vaccine Therapy With or Without Cryosurgery in Treating Patients With Residual, Relapsed, or Refractory B-Cell Non-Hodgkin Lymphoma dendritic cell vaccine therapy, cryotherapy, pneumococcal polyvalent vaccine - Cutaneous B-cell Non-Hodgkin Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Early Phase 1 | Completed | Mayo Clinic | 16 | 2010-11-01 | 2020-01-14 |
| ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme temozolomide, veliparib, DNA methylation analysis - Brain and Central Nervous System Tumors | Phase 1 | Completed | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 24 | 2009-07-13 | 2018-06-27 |
| Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma epirubicin hydrochloride, ifosfamide, sorafenib tosylate - Sarcoma | Phase 1 | Completed | OHSU Knight Cancer Institute | 18 | 2009-02-01 | 2018-09-07 |
| Laboratory-Treated T Cells and Ipilimumab in Treating Patients With Metastatic Melanoma ipilimumab, cyclophosphamide, biopsy - Recurrent Melanoma, Stage IV Melanoma | Phase 1 / Phase 2 | Completed | Fred Hutchinson Cancer Center | 10 | 2009-02-01 | 2017-04-19 |
| Stereotactic Radiosurgery and Erlotinib in Treating Patients With Non-Small Cell Lung Cancer and Brain Metastases erlotinib hydrochloride, immunoenzyme technique, laboratory biomarker analysis - Lung Cancer, Metastatic Cancer | Phase 1 | Withdrawn | University of California, San Francisco | 2009-01-01 | 2012-10-04 | |
| Paricalcitol in Treating Patients With Advanced Prostate Cancer and Bone Metastases paricalcitol, immunoenzyme technique, laboratory biomarker analysis - Metastatic Cancer, Prostate Cancer | Phase 2 | Terminated | Wake Forest University Health Sciences | 2 | 2009-01-01 | 2018-07-06 |
| Trastuzumab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With High-Risk or Metastatic Breast Cancer allogeneic GM-CSF-secreting breast cancer vaccine, trastuzumab, cyclophosphamide - Breast Cancer | Phase 2 | Completed | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 20 | 2008-12-01 | 2018-09-26 |
| Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast Cancer imiquimod, Abraxane, laboratory biomarker analysis - Male Breast Cancer, Recurrent Breast Cancer | Phase 2 | Completed | University of Washington | 15 | 2008-12-01 | 2018-01-02 |
| Exercise Programs in Healthy Young Women at Increased Risk of Developing Breast Cancer exercise intervention, counseling intervention, gas chromatography - Breast Cancer, Healthy, no Evidence of Disease | Not applicable | Completed | Abramson Cancer Center at Penn Medicine | 183 | 2008-10-01 | 2020-04-16 |
| Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer cyclosporine, mycophenolate mofetil, pentostatin - Chronic Myeloproliferative Disorders, Leukemia | Phase 1 / Phase 2 | Withdrawn | University of Nebraska | 2008-09-01 | 2023-08-14 | |
| Vaccine Therapy in Treating Patients With Previously Treated Stage II or Stage III Breast Cancer CpG oligodeoxynucleotide, HER-2/neu peptide vaccine, MUC-1 peptide vaccine - Breast Cancer | Early Phase 1 | Completed | Mayo Clinic | 45 | 2008-08-28 | 2018-10-31 |
| Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer carboplatin, paclitaxel albumin-stabilized nanoparticle formulation, protein expression analysis - Lung Cancer | Phase 2 | Completed | Greg Otterson | 63 | 2008-08-14 | 2018-04-02 |
| Blood Samples From Patients on a Clinical Trial to CINV During HSCT immunoenzyme technique, laboratory biomarker analysis, medical chart review - Breast Cancer, Chronic Myeloproliferative Disorders | Terminated | OHSU Knight Cancer Institute | 9 | 2008-08-01 | 2017-05-09 | |
| Studying Blood Samples From Patients With Multiple Myeloma Who Were Treated With Thalidomide or Lenalidomide gene expression analysis, reverse transcriptase-polymerase chain reaction, immunoenzyme technique - Multiple Myeloma and Plasma Cell Neoplasm | Completed | Eastern Cooperative Oncology Group | 33 | 2008-07-04 | 2017-05-17 | |
| Anti-IMP3 Autoantibody and MicroRNA Signature Blood Tests in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer gene expression analysis, protein expression analysis, diagnostic laboratory biomarker analysis - Kidney Cancer | Completed | City of Hope Medical Center | 155 | 2008-07-01 | 2017-12-08 | |
| Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer autologous Epstein-Barr virus-specific cytotoxic T lymphocytes, carboplatin, gemcitabine hydrochloride - Head and Neck Cancer | Phase 2 | Unknown | National Cancer Centre, Singapore | 35 | 2008-07-01 | 2009-06-29 |
Showing 20 of 88. Sign in to see all of them.
Breast Neoplasms (22) · Carcinoma, Non-Small-Cell Lung (12) · Lung Neoplasms (10) · Head and Neck Neoplasms (8) · Leukemia, Lymphocytic, Chronic, B-Cell (8) · Lymphoma, B-Cell, Marginal Zone (8) · Lymphoma, Follicular (8) · Lymphoma, Mantle-Cell (8) · Lymphoma, Non-Hodgkin (8) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (8) · Breast Neoplasms, Male (7) · Congenital Abnormalities (7) · Carcinoma, Ovarian Epithelial (6) · Leukemia (6) · Lymphoma, Large B-Cell, Diffuse (6)
Memorial Sloan Kettering Cancer Center (9) · City of Hope Medical Center (7) · Case Comprehensive Cancer Center (5) · Mayo Clinic (5) · National Cancer Institute (NCI) (4) · University of Washington (4) · ECOG-ACRIN Cancer Research Group (3) · National Cancer Centre, Singapore (3) · OHSU Knight Cancer Institute (3) · Roswell Park Cancer Institute (3) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (3) · Vanderbilt University Medical Center (3) · Wake Forest University Health Sciences (3) · Abramson Cancer Center at Penn Medicine (2) · Barbara Ann Karmanos Cancer Institute (2)
United States (63) · Canada (3) · Singapore (3) · United Kingdom (2) · Belgium (1) · France (1) · Switzerland (1)
Svetomir Markovic, MD, PhD (3) · Wendell G. Yarbrough, MD, FACS (3) · Angela Davies, MD (2) · Lupe Salazar (2) · Toh Han Chong, MD, MBBS, MRCP (2) · Vincent Chung, MD (2) · Alan N. Houghton, MD (1) · Alex A. Adjei, MD, PhD (1) · Alison T. Stopeck, MD (1) · Andrew D. Zelenetz, MD, PhD (1) · Antonio Omuro, MD (1) · Aude Chapuis (1) · Barbara A Pockai, M.D. (1) · Charles M. Rudin, MD, PhD (1) · Christopher W. Ryan, MD (1)
PMID 16469108, PMID 17551310, PMID 17570509, PMID 18090584, PMID 20063546, PMID 20400682, PMID 21285985, PMID 21677464, PMID 22044694, PMID 23243055, PMID 24386300, PMID 24987057, PMID 26123189, PMID 26130251, PMID 27269940, PMID 28114604, PMID 28679643, PMID 31319977, PMID 34615429, PMID 35135810, PMID 36326756
P30CA008748 (5), P30CA033572 (4), P30CA015083 (3), P30CA043703 (3), P30CA068485 (3), P30CA006973 (2), P30CA012197 (2), P30CA022453 (2), P30CA023074 (2), P30CA036727 (2), P30CA069533 (2), K12CA076930 (1), N01CM17101 (1), N01CN35158 (1), N01CN35160 (1)